Recent Finacing
Recent Raise
MyoTherix is a biotech developing mutation-agnostic therapeutics for Duchenne and other muscular dystrophies, advancing preclinical programs to improve cardiac and skeletal muscle function, reduce inflammation, and promote regeneration.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor